Zhi Wang Chen
Direttore Finanziario/CFO presso VANFUND URBAN INVESTMENT AND DEVELOPMENT CO., LTD.
Provenienza dei contatti di primo grado di Zhi Wang Chen
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Packaged Software | 15 | |
Harbin Zhudinggongda New Materials Technology Co., Ltd.
 Harbin Zhudinggongda New Materials Technology Co., Ltd. Other Metals/MineralsNon-Energy Minerals Harbin Zhudinggongda New Materials Technology Co., Ltd. is a company that manufactures non-ferrous metal alloy materials. The company is based in Harbin, China. The Chinese company was founded in 2015. The CEO is Da Wei Xing.
3
| Holding Company | Other Metals/Minerals | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Zhi Wang Chen tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| PENGQI TECHNOLOGY DEVELOPMENT CO., LTD. | Industrial Machinery | Chairman | |
| Southwest University | College/University | Undergraduate Degree | |
Wisefund Investment Holding Group Co., Ltd.
 Wisefund Investment Holding Group Co., Ltd. Real Estate DevelopmentFinance Wisefund Investment Holding Group Co., Ltd. is an investment holding company based in China. The Chinese company has interests in real estate development and mining, among other industries. Bin Hang has been the CEO of the company since 2004. | Real Estate Development | President | |
| TIBET AIM PHARM. INC. | Pharmaceuticals: Other | Director/Board Member | |
Jilin Wanfang Baiao Biotechnology Co., Ltd.
 Jilin Wanfang Baiao Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Vanfund Urban Investment & Development Co., Ltd., Jilin Wanfang Baiao Biotechnology Co., Ltd. manufactures and sells pharmaceutical products. The company is based in Changchun, China. The Chinese company was founded in 2020. The CEO is Feng Chun Qi. Jilin Wanfang Baiao Biotechnology Co. was acquired by Vanfund Urban Investment & Development Co., Ltd. on January 26, 2022 for $3.29 million. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
| Cina | 5 |
| Stati Uniti | 2 |
Settori
| Health Technology | 3 |
| Producer Manufacturing | 2 |
| Consumer Services | 2 |
| Finance | 2 |
Posizioni
| Director/Board Member | 18 |
| Chairman | 5 |
| Independent Dir/Board Member | 5 |
| Corporate Secretary | 4 |
| Chief Executive Officer | 3 |
Contatti più connessi
| Insiders | |
|---|---|
| Xing Gang Xiao | 3 |
| Yu Liu | 3 |
| Han Hui Zhang | 2 |
| Hui Zhang | 2 |
| Zi Bin Guo | 2 |
| Ting Wang | 1 |
| Xin Yi Wang | 1 |
| Li Li Sun | 1 |
| Wei Qiang Song | 1 |
| Zong Li Zhang | 1 |
| Da Wei Xing | 1 |
| Bo Zhang | 1 |
| Jian Qing Su | 1 |
| Ge Lin Liu | 1 |
| Chun Jing Wei | 1 |
- Borsa valori
- Insiders
- Zhi Wang Chen
- Connessioni Società
